2 MATTERS TO DISCUSS RE KNR BioCloud and COVID19
Most people probably were unaware that the EBOLA vaccine was developed in Winnipeg, Canada at the Federal laboratory. Due to political pressure, the FDA approval required it to be released from a small company in USA so they could take the credit. I mention that because I have a friend who was part of the Canadian team. She is now in Britain as they develop a vaccine for COVVID19 and I have talked to her re the BioCloud of KNR.
She is very impressed with this development, particularly [and I am not sure why] the fact that they can “recognize” the COVID 19 virus and MOST important, that management says they have the ability to use this method for Any virus, fungi,or bacteria. Eventually, there will be a working vaccine for COVID 19 but that doesn’t make the BioCloud device obsolete. Animal to human transmissions are going to happen more often and the BioCFloud will be a major weapon in containment. My friend asked me to ask a few questions but the Investor Relations contact is too busy to respond.
Listening to Question Period [Canadian News program] today, they stated the major problem right now is the lack of ‘instant’ testing ability for the COVID 19 virus as we face the coming Flu season. That.s were BioCloud will help solve the problem!! The federal government and Provinces will be dealing with expenditures to fight the battles, so, hopefully, we will see contracts signed in the coming weeks.